EUPRAXIA PHARMACEUTICALS INC. Additional Paid in Capital, Common Stock
EUPRAXIA PHARMACEUTICALS INC. (EPRX) had Additional Paid in Capital, Common Stock of $28.52 million as of 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-03-13
- 2025-12-31: Additional Paid in Capital, Common Stock $28.52M.
- 2024-12-31: Additional Paid in Capital, Common Stock $20.50M.
- 2023-12-31: Additional Paid in Capital, Common Stock $17.51M.
- 2022-12-31: Additional Paid in Capital, Common Stock $16.85M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2025-12-31 | $28.52M 40-F · filed 2026-03-13 |
| 2024-12-31 | $20.50M 40-F · filed 2026-03-13 |
| 2023-12-31 | $17.51M 40-F · filed 2025-03-20 |
| 2022-12-31 | $16.85M 40-F · filed 2024-04-01 |